Open-label Extension Study Of RN624
NCT00399490
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
287
Enrollment
INDUSTRY
Sponsor class
Conditions
Osteoarthritis
OA Knee Pain
Arthritis
Interventions
DRUG:
RN624 (PF-04383119)
Sponsor
Pfizer